About Neuromeda JSC
"Įstaiga orientuojasi tiek suaugusiųjų, tiek vaikų ir paauglių psichiatrinės, psichologinės, psichoterapinės, neurologinės pagalbos ir fizinės reabilitacijos paslaugų teikimą. Įstaigoje dirba visi šios pagalbos teikimui reikalingi specialistai bei konsultantai. Įstaigoje dirbantys psichoterapeutai atstovauja įvairias psichoterapijos sritis, įskaitant psichodinaminę, egzistencinę, sisteminę šeimos bei kognityvinę elgesio psichoterapiją. Toks platus psichoterapinių paslaugų spektras leidžia konsultuoti asmenis su įvairaus pobūdžio problemomis ir poreikiais, o taip pat konsultuoti tiek pavienius asmenis, tiek poras."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Sunovion
3
ACADIA Pharmaceuticals Inc.
2
Forest Laboratories
1
Janssen Research & Development, LLC
1
Clinical Trials at Neuromeda JSC
During the past decade, Neuromeda JSC conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
2009-04-01
2013-02-01
Completed
817
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
2010-11-01
2012-08-01
Completed
356
Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
2016-03-17
2017-07-19
Completed
488
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia
2017-01-01
2024-03-01
Recruiting
500
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
2020-09-15
2023-11-24
Recruiting
720
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
2020-08-05
2024-01-01
Recruiting
426
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Neuromeda JSC
According to Clinical.Site data, the most researched conditions in "Neuromeda JSC" are
"Schizophrenia" (3 trials), "Bipolar Depression" (2 trials), "Bipolar Disorder" (2 trials), "Depression" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Neuromeda JSC" in a lesser frequency.
Clinical Trials Intervention Types at Neuromeda JSC
Most popular intervention types in "Neuromeda JSC" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lurasidone" (2 trials), "Pimavanserin" (2 trials), "Cariprazine" (1 trials) and "Matching placebo to Quetiapine XR" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Neuromeda JSC
The vast majority of trials in "Neuromeda JSC" are
7 trials for "All" genders.
Clinical Trials Status at Neuromeda JSC
Currently, there are NaN active trials in "Neuromeda JSC".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Neuromeda JSC,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Neuromeda JSC, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Neuromeda JSC
Neuromeda JSC has several departments that took part in Clinical trials: "Neuromeda" - 2 trials
Departments List
Name
City
Trials